Psychedelic-Assisted Therapy: Applications in Mental Health
A deep dive into clinical efficacy and safety of using psychedelic-assisted therapy for depression, anxiety, PTSD, substance use disorder, and other mental health disorders
A deep dive into clinical efficacy and safety of using psychedelic-assisted therapy for depression, anxiety, PTSD, substance use disorder, and other mental health disorders
The vast majority of NPs and PAs report symptoms of moral injury such as anxiety, PTSD, and suicidality in The Clinical Advisor’s online survey.
After 3 years of battling COVID-19, and close to 1 million deaths, the mental health toll of the pandemic is evident everywhere.
In female veterans, posttraumatic stress disorder (PTSD) is associated with an increased risk for ischemic heart disease.
The researchers assessed the effectiveness and implementation of stepped collaborative care intervention for posttraumatic stress disorder.
The researchers sought to find out whether the prevalence of PTSD in COVID-19 survivors was similar to that of survivors of previous coronavirus epidemics.
The researchers conducted genome-wide association studies of PTSD in military veterans to explore the genetic association with the common comorbidities of depression and anxiety.
By understanding the time-varying association of pre-migration and post-migration stressors in the mental health of refugees, tailored health promotion services could be designed for different resettlement stages thus improving the efficiency of resource allocation.
The study examined whether CBT reduced anger and aggression in a group of veterans and to compare the efficacy of CBT with psychoeducation.
Six months after hematopoietic stem cell transplantation, nearly 20% of enrolled patients had experienced clinically significant PTSD symptoms.